2014 Medical Countermeasures Initiative (MCMi) Regulatory Science Symposium
June 2-3, 2014 FDA Headquarters White Oak Campus Silver Spring, Maryland
On June 2-3, 2014, FDA will host its 3rd public Medical Countermeasures Initiative (MCMi) Regulatory Science Symposium to:
(1) Update stakeholders on FDA’s current MCM activities and recent accomplishments,
(2) Highlight progress of ongoing intramural regulatory science research activities, and
(3) Discuss the future of MCMi regulatory science.
This event is free, and open to the public. Advance registration is required.
FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA’s responsibility is to ensure that medical countermeasures (MCMs)—such as drugs, vaccines, and diagnostic tests—to counter these threats are safe, effective, and secure.